-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Zymeworks, Raises Price Target to $40

Benzinga·11/21/2025 16:22:21
Listen to the news
B. Riley Securities analyst Mayank Mamtani reiterates Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $30 to $40.